Natixis Advisors LLC Invests $288,000 in Simulations Plus, Inc. (NASDAQ:SLP)

Natixis Advisors LLC bought a new stake in shares of Simulations Plus, Inc. (NASDAQ:SLP) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 10,337 shares of the technology company’s stock, valued at approximately $288,000. Natixis Advisors LLC owned 0.05% of Simulations Plus as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Quantbot Technologies LP bought a new stake in Simulations Plus in the 3rd quarter valued at $59,000. BNP Paribas Financial Markets grew its position in Simulations Plus by 402.9% during the third quarter. BNP Paribas Financial Markets now owns 39,944 shares of the technology company’s stock worth $1,279,000 after buying an additional 32,002 shares in the last quarter. Verition Fund Management LLC raised its holdings in Simulations Plus by 120.5% in the 3rd quarter. Verition Fund Management LLC now owns 10,365 shares of the technology company’s stock valued at $332,000 after acquiring an additional 5,665 shares in the last quarter. Petrus Trust Company LTA bought a new stake in shares of Simulations Plus in the 3rd quarter worth approximately $682,000. Finally, State Street Corp grew its holdings in shares of Simulations Plus by 4.7% during the 3rd quarter. State Street Corp now owns 640,303 shares of the technology company’s stock worth $20,503,000 after purchasing an additional 28,953 shares in the last quarter. Institutional investors and hedge funds own 78.08% of the company’s stock.

Simulations Plus Stock Performance

SLP opened at $24.29 on Friday. The firm has a market cap of $488.03 million, a price-to-earnings ratio of 60.73 and a beta of 0.89. The firm’s 50-day simple moving average is $30.80 and its 200-day simple moving average is $30.57. Simulations Plus, Inc. has a twelve month low of $23.63 and a twelve month high of $51.22.

Insiders Place Their Bets

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $33.91, for a total value of $678,200.00. Following the transaction, the director now owns 3,402,584 shares of the company’s stock, valued at approximately $115,381,623.44. The trade was a 0.58 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 19.40% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on SLP shares. KeyCorp upped their target price on Simulations Plus from $35.00 to $37.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. William Blair reaffirmed an “outperform” rating on shares of Simulations Plus in a report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $49.40.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.